Novation recognizes APP with NOVAPLUS Pharmacy Manufacturer of the Year

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., has been named NOVAPLUS® Pharmacy Manufacturer of the Year by Novation, the industry's leading supply contracting company. This prestigious award recognizes APP's ability to provide Novation's members access to critical drugs, including those affected by market-wide shortages.

"APP Pharmaceuticals is honored to receive the NOVAPLUS Pharmacy Manufacturer of the Year Award from such a valued customer," said John Ducker, President and Chief Executive Officer of APP Pharmaceuticals. "Throughout the year, our team has worked hard to supply Novation's members with several critically needed drugs. This award not only recognizes the company's efforts, but those of each APP employee and their commitment to meeting our customers' expectations."

Scott Meacham, Executive Vice President and Chief Commercial Officer, APP Pharmaceuticals, added, "Our most important goal is to support the needs of our customers by providing them a broad portfolio of drugs. By doing so, we are able to impact the lives of the patients they treat."

"APP Pharmaceuticals received the NOVAPLUS Pharmacy Manufacturer of the Year Award in recognition of their exceptional support and commitment toward helping Novation members achieve their supply chain goals," explained Pete Allen, Senior Vice President, Sourcing Operations, Novation. "APP Pharmaceuticals has truly exemplified the attributes set forth in the award criteria."